Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ADAGRASIB vs ADALIMUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ADAGRASIB vs ADALIMUMAB: Safety Overview

Metric ADAGRASIB ADALIMUMAB
Total FAERS Reports 899 499,856
Deaths Reported 315 21,807
Death Rate 35.0% 4.4%
Hospitalizations 350 108,264
Average Patient Age 68.3 yrs 50.9 yrs
% Female Patients 56.4% 67.6%
FDA Approval Date Dec 12, 2022 N/A
Manufacturer Mirati Therapeutics, Inc Coherus BioSciences Inc
Route ORAL SUBCUTANEOUS
Marketing Status Prescription Prescription